Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Retrospective Multicenter Analysis on 285 Procedures Performed between 2000 and 2020

Blood (2024) 144 (Supplement 1): 2186.

https://doi.org/10.1182/blood-2024-194320

Published: 2024

Journal Articles

Multiparametric Flow-Cytometry Is a Reliable Tool for Measurable Residual Disease Assessment and Risk-Stratification of FLT3-Mutated AML Patients

Blood (2019) 134 (Supplement_1): 5083.

https://doi.org/10.1182/blood-2019-129184

Published: 2019

Journal Articles

Clinical Significance of Occult Central Nervous System Disease in Adult ACUTE Lymphoblastic Leukemia. a Multicenter,Report from the Campus ALL/Gimema Network

Blood (2018) 132 (Supplement 1): 658.

https://doi.org/10.1182/blood-2018-99-114177

Published: 2018

Journal Articles

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Blood (2016) 128 (22): 2789.

https://doi.org/10.1182/blood.V128.22.2789.2789

Published: 2016

Journal Articles

Haploidentical, G-CSF Primed, Unmanipulated Bone Marrow Transplantation with Anti-CD25 Monoclonal Antibody As Part of the Gvhd Prophylaxis for Patients with High-Risk Acute Myeloid Leukemia

Blood (2015) 126 (23): 4368.

https://doi.org/10.1182/blood.V126.23.4368.4368

Published: 2015

Journal Articles

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Blood (2015) 126 (23): 2004.

https://doi.org/10.1182/blood.V126.23.2004.2004

Published: 2015

Journal Articles

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, Maria Ilaria Del Principe, MD, Gottardo De Angelis, MD, Ambra Di Veroli, MD, Raffaella Cerretti, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Benedetta Mariotti, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2015) 126 (23): 3230.

https://doi.org/10.1182/blood.V126.23.3230.3230

Published: 2015

Journal Articles

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Francesco Buccisano, MD, Luca Maurillo, MD, Maria Ilaria Del Principe, Gottardo De Angelis, MD, Raffaella Cerretti, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Mariagiovanna Cefalo, MD, Chiara Sarlo, MD, Giorgia Fedele, MD, Marco Refrigeri, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, Adriano Venditti

Blood (2014) 124 (21): 2363.

https://doi.org/10.1182/blood.V124.21.2363.2363

Published: 2014

Journal Articles

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Blood (2014) 124 (21): 1223.

https://doi.org/10.1182/blood.V124.21.1223.1223

Published: 2014

Journal Articles

Haploidentical, Unmanipulated, G-CSF-Primed Bone Marrow Transplantation For Patients With High-Risk Acute Myeloid Leukemia

William Arcese, MD, Raffaella Cerretti, MD, Stella Santarone, MD, Alessandra Picardi, MD, Manuela Testi, Laura Cudillo, MD, Francesco Buccisano, MD, Teresa Dentamaro, MD, Fabio Di Piazza, Gottardo De Angelis, Paolo Di Bartolomeo, MD

Blood (2013) 122 (21): 3356.

https://doi.org/10.1182/blood.V122.21.3356.3356

Published: 2013

Journal Articles

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

Paolo Di Bartolomeo, Stella Santarone, Gottardo De Angelis, Alessandra Picardi, Laura Cudillo, Raffaella Cerretti, Gaspare Adorno, Stefano Angelini, Marco Andreani, Lidia De Felice, Maria Cristina Rapanotti, Loredana Sarmati, Pasqua Bavaro, Gabriele Papalinetti, Marta Di Nicola, Franco Papola, Mauro Montanari, Arnon Nagler, William Arcese

Blood (2013) 121 (5): 849–857.

https://doi.org/10.1182/blood-2012-08-453399

Published: 2013

Journal Articles

Unmanipulated Graft Transplantation From Family Haploidentical Donors: A Survey On 183 Adult Patients with Acute Leukemias On Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Fabio Ciceri, MD, Myriam Labopin, Paolo Di Bartolomeo, MD, William Arcese, MD, Stella Santarone, MD, Gottardo De Angelis, Jacopo Peccatori, MD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 1987.

https://doi.org/10.1182/blood.V120.21.1987.1987

Published: 2012

Journal Articles

Unmanipulated, G-CSF-Primed Bone Marrow Transplantation From Haploidentical Donor for Patients with High-Risk Acute Myeloid Leukemia.

William Arcese, MD, Raffaella Cerretti, MD, Stella Santarone, MD, Gottardo De Angelis, MD, Pasqua Bavaro, MD, Manuela Testi, MD, Laura Cudillo, MD, Alessandra Picardi, MD, Elsa Pennese, MD, Gabriele Papalinetti, MD, Teresa Dentamaro, MD, Eleonora Ceresoli, MD, Benedetta Mariotti, MD, Fabio Di Piazza, Paolo Di Bartolomeo, MD

Blood (2012) 120 (21): 3122.

https://doi.org/10.1182/blood.V120.21.3122.3122

Published: 2012

Journal Articles

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Blood (2010) 116 (21): 2702.

https://doi.org/10.1182/blood.V116.21.2702.2702

Published: 2010

Journal Articles

Unmanipulated Bone Marrow Transplantation From Haploidentical Related Donor for Patients with High-Risk Hematological Malignancies

Paolo Di Bartolomeo, MD, Stella Santarone, MD, Gottardo De Angelis, Alessandra Picardi, Pasqua Bavaro, Erminia Di Bartolomeo, Paola Olioso, Marta Di Nicola, Lidia De Felice, Laura Cudillo, Raffaella Cerretti, William Arcese

Blood (2010) 116 (21): 2350.

https://doi.org/10.1182/blood.V116.21.2350.2350

Published: 2010

Journal Articles

Non T-Depleted Bone Marrow Transplantation From Haploidentical Related Donor in Hematological Malignancies.

Stella Santarone, MD, Gottardo De Angelis, Erminia Di Bartolomeo, Pasqua Bavaro, Mauro Montanari, MD, Pietro Leoni, Raffaella Cerretti, Paolo Di Bartolomeo, MD, William Arcese, MD

Blood (2009) 114 (22): 2291.

https://doi.org/10.1182/blood.V114.22.2291.2291

Published: 2009

Journal Articles

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Blood (2009) 114 (22): 1195.

https://doi.org/10.1182/blood.V114.22.1195.1195

Published: 2009

Journal Articles

Decisional Algorithm to Incorporate Hematopoietic Stem Cell Transplantation in the Management of Adult Patients with Acute Myeloid Leukaemia.

Francesco Buccisano, M.D., Luca Maurillo, Maria Ilaria Del Principe, Giovanni Del Poeta, Paola Panetta, Emanuele Ammatuna, Licia Ottaviani, Chiara Sarlo, Micol Quaresima, Gottardo De Angelis, Manuela Rizzo, Selenia Campagna, Francesco Lo Coco, William Arcese, Sergio Amadori, Adriano Venditti

Blood (2008) 112 (11): 1519.

https://doi.org/10.1182/blood.V112.11.1519.1519

Published: 2008

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Retrospective Multicenter Analysis on 285 Procedures Performed between 2000 and 2020

Multiparametric Flow-Cytometry Is a Reliable Tool for Measurable Residual Disease Assessment and Risk-Stratification of FLT3-Mutated AML Patients

Clinical Significance of Occult Central Nervous System Disease in Adult ACUTE Lymphoblastic Leukemia. a Multicenter,Report from the Campus ALL/Gimema Network

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Haploidentical, G-CSF Primed, Unmanipulated Bone Marrow Transplantation with Anti-CD25 Monoclonal Antibody As Part of the Gvhd Prophylaxis for Patients with High-Risk Acute Myeloid Leukemia

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Haploidentical, Unmanipulated, G-CSF-Primed Bone Marrow Transplantation For Patients With High-Risk Acute Myeloid Leukemia

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

Unmanipulated Graft Transplantation From Family Haploidentical Donors: A Survey On 183 Adult Patients with Acute Leukemias On Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Unmanipulated, G-CSF-Primed Bone Marrow Transplantation From Haploidentical Donor for Patients with High-Risk Acute Myeloid Leukemia.

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Unmanipulated Bone Marrow Transplantation From Haploidentical Related Donor for Patients with High-Risk Hematological Malignancies

Non T-Depleted Bone Marrow Transplantation From Haploidentical Related Donor in Hematological Malignancies.

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Decisional Algorithm to Incorporate Hematopoietic Stem Cell Transplantation in the Management of Adult Patients with Acute Myeloid Leukaemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only